We are live on
!
Find out more
CIA
Cascade Investment Advisors Portfolio holdings
AUM
$183M
1-Year Est. Return
29.64%
This Fund
S&P 500
This Quarter
Est. Return
-2.98%
1 Year Est. Return
+29.64%
3 Year Est. Return
+71.4%
5 Year Est. Return
+90.78%
10 Year Est. Return
–
AUM
$126M
AUM Growth
-$7.52M
(-5.6%)
Cap. Flow
-$2.51M
Cap. Flow
% of AUM
-1.99%
Top 10 Holdings %
Top 10 Hldgs %
20.5%
Holding
117
New
7
Increased
45
Reduced
41
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.67M |
| 2 |
Sanofi
SNY
|
+$1.24M |
| 3 |
Integra LifeSciences
IART
|
+$1.06M |
| 4 |
Columbus McKinnon
CMCO
|
+$996K |
| 5 |
AGCO
AGCO
|
+$820K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.63M |
| 2 |
Citigroup
C
|
+$1.21M |
| 3 |
Stanley Black & Decker
SWK
|
+$1.2M |
| 4 |
Northwest Natural Holdings
NWN
|
+$1.16M |
| 5 |
Walt Disney
DIS
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Industrials | 14.63% |
| 4 | Real Estate | 9.69% |
| 5 | Financials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Abbott
ABT
$183B
| $231K | 0.18% |
2,386
-200
| -8% | -$21K |
|
102
Coca-Cola
KO
$374B
| $218K | 0.17% |
3,895
| – | – |
|
103
Gilead Sciences
GILD
$164B
| $216K | 0.17% |
2,885
| – | – |
|
104
Eli Lilly
LLY
$1.04T
| $208K | 0.16% |
+387
| New | +$199K |
|
105
McKesson
MCK
$103B
| $200K | 0.16% |
+460
| New | +$194K |
|
106
A10 Networks
ATEN
$2.22B
| – | – |
-42,070
| Closed | -$614K |
|
|
107
Citigroup
C
$231B
| – | – |
-26,365
| Closed | -$1.21M |
|
108
D.R. Horton
DHI
$42.4B
| – | – |
-3,293
| Closed | -$401K |
|
|
109
Walt Disney
DIS
$177B
| – | – |
-12,298
| Closed | -$1.1M |
|
|
GRMN
110
Garmin
GRMN
$58.3B
| – | – |
-8,254
| Closed | -$861K |
|
111
Honeywell
HON
$78.6B
| – | – |
-1,125
| Closed | -$220K |
|
112
KB Home
KBH
$3.61B
| – | – |
-9,765
| Closed | -$505K |
|
113
Merck
MRK
$317B
| – | – |
-1,893
| Closed | -$218K |
|
|
114
Northwest Natural Holdings
NWN
$2.08B
| – | – |
-26,904
| Closed | -$1.16M |
|
|
115
Regeneron Pharmaceuticals
REGN
$79.1B
| – | – |
-2,275
| Closed | -$1.63M |
|
|
116
Stanley Black & Decker
SWK
$15.6B
| – | – |
-12,810
| Closed | -$1.2M |
|
117
Toll Brothers
TOL
$14.5B
| – | – |
-7,150
| Closed | -$565K |
|
Similar funds
OWG
KSCM
GCGM
BIG
BWA
MCM
IFPL
RMC
Cascade Investment Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Cascade Investment Advisors held 117 positions worth $126M, down 5.6% from $134M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cascade Investment Advisors's Q3 2023 filing shows 7 new, 45 increased, 41 reduced and 12 closed positions. Its largest new stake was Pfizer: 47,089 shares worth $1.56M. The largest sale was Regeneron Pharmaceuticals, an estimated $1.63M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Cascade Investment Advisors's largest Q3 2023 buy was Pfizer: 47,089 shares worth $1.56M.
- Cascade Investment Advisors added most to Rogers Communications in Q3 2023, an estimated $403K increase.
- Cascade Investment Advisors's biggest Q3 2023 reduction was Apple, cutting an estimated $400K.
- Cascade Investment Advisors fully exited Regeneron Pharmaceuticals in Q3 2023, selling an estimated $1.63M.
- Cascade Investment Advisors's ten largest holdings make up 20% of its $126M portfolio in Q3 2023.
- Cascade Investment Advisors opened 7 new positions and closed 12 in Q3 2023.
- Cascade Investment Advisors's portfolio value fell 5.6% quarter-over-quarter to $126M.
Based on Cascade Investment Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.